In this randomized controlled trial, supplementation with a low dose of carrot-derived rhamnogalacturonan I (a type of fiber) reduced the length and peak severity of symptoms of the common cold compared with a placebo or a high dose of RG-I.
This Study Summary was published on January 31, 2022.